Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized Open Label Study of Rapamune-Based Regimens in De Novo Renal Allograft Recipients
2004-000363-10Phase 4Completed
- Sponsor
- Wyeth
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sirolimus in kidney allograft rejection (3 arms), sponsored by Wyeth. Primary endpoint: Calculated creatinine clearance at 12 months. Started May 2005; status: completed.
02
Drugs
sirolimus
03
Conditions
kidney allograft rejection
Beyond the preview
Go deeper on 2004-000363-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000363-10.